FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Biochimica et biophysica acta2011; 1812(9); 1098-1103; doi: 10.1016/j.bbadis.2011.02.007

Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissues without change in AS160 activation.

Abstract: Although the importance of adipose tissue (AT) glucose transport in regulating whole-body insulin sensitivity is becoming increasingly evident and insulin resistance (IR) has been widely recognized, the underlying mechanisms of IR are still not well understood. The purpose of the present study was to determine the early pathological changes in glucose transport by characterizing the alterations in glucose transporters (GLUT) in multiple visceral and subcutaneous adipose depots in a large animal model of naturally occurring compensated IR. AT biopsies were collected from horses, which were classified as insulin-sensitive (IS) or compensated IR based on the results of an insulin-modified frequently sampled intravenous glucose tolerance test. Protein expression of GLUT4 (major isoform) and GLUT12 (one of the most recently discovered isoforms) were measured by Western blotting in multiple AT depots, as well as AS160 (a potential key player in GLUT trafficking pathway). Using a biotinylated bis-mannose photolabeled technique, active cell surface GLUT content was quantified. Omental AT had the highest total GLUT content compared to other sites during the IS state. IR was associated with a significantly reduced total GLUT4 content in omental AT, without a change in content in other visceral or subcutaneous adipose sites. In addition, active cell surface GLUT-4, but not -12, was significantly lower in AT of IR compared to IS horses, without change in AS160 phosphorylation between groups. Our data suggest that GLUT4, but not GLUT12, is a pathogenic factor in AT during naturally occurring compensated IR, despite normal AS160 activation.
Copyright © 2011 Elsevier B.V. All rights reserved.
Get Full Text
Publication Date: 2011-02-23 PubMed ID: 21352908PubMed Central: PMC3143249DOI: 10.1016/j.bbadis.2011.02.007Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explores how a naturally occurring insulin resistance impacts glucose transporters in fat tissues, with results indicating that the GLUT4 transporter could be implicated in disease onset but not GLUT12, under certain circumstances of insulin resistance.

Context and Purpose

  • The study is aimed at understanding the role of adipose tissue (AT) – fat tissue – in regulating insulin sensitivity, an important aspect of diabetes research. Despite recognition of insulin resistance as a key aspect of metabolic disorders, the underlying mechanisms are still not fully understood.
  • The researchers want to particularly understand the early pathological changes occurring in glucose transport. They aim to do this by studying changes to glucose transporters – proteins that help move glucose into cells – in various visceral (deep abdominal fat tissue) and subcutaneous (just beneath the skin) fat depots, in a large animal model of naturally occurring insulin resistance.

Methodology

  • The researchers collected AT biopsies from horses. Based on insulin-modified frequently sampled intravenous glucose tolerance tests, the horses were classified as either insulin-sensitive (IS) or having compensated insulin resistance (IR).
  • The researchers checked protein expression levels of two glucose transporters, GLUT4 and GLUT12, using a technique called Western blotting. GLUT4 is a major isoform, while GLUT12 is one of the most recently discovered ones. They also checked AS160 protein, which could potentially play a role in the Glut trafficking pathway.
  • A technique called the biotinylated bis-mannose photolabeled technique was used to quantify active cell surface GLUT content.

Findings

  • The omental AT (fat inside the abdominal cavity) had the highest total GLUT content during the insulin-sensitive state.
  • Compensated IR was associated with a significant reduction in total GLUT4 content in the omental AT, but there was no change in content in other visceral or subcutaneous fat sites.
  • Active cell surface GLUT4, but not GLUT12, was significantly lower in AT of IR compared to IS horses. However, the AS160 phosphorylation (an important process for protein function) didn’t show a difference between groups.

Implications

  • The results suggest that a reduction in GLUT4, but not GLUT12, might be an underlying factor in the pathogenesis of compensated insulin resistance within adipose tissue.
  • The observation that these changes occur despite normal AS160 activation imply that the GLUT4-mediated insulin resistance might happen via different mechanisms not necessarily linked to AS160 function.

Cite This Article

APA
Waller AP, Kohler K, Burns TA, Mudge MC, Belknap JK, Lacombe VA. (2011). Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissues without change in AS160 activation. Biochim Biophys Acta, 1812(9), 1098-1103. https://doi.org/10.1016/j.bbadis.2011.02.007

Publication

Biochimica et biophysica acta
ISSN: 0006-3002
NlmUniqueID: 0217513
Country: Netherlands
Language: English
Volume: 1812
Issue: 9
Pages: 1098-1103

Researcher Affiliations

Waller, A P
  • College of Pharmacy, 500 W. 12th Avenue, The Ohio State University, Columbus, OH 43215, USA.
Kohler, K
    Burns, T A
      Mudge, M C
        Belknap, J K
          Lacombe, V A

            MeSH Terms

            • Animals
            • GTPase-Activating Proteins / physiology
            • Glucose Tolerance Test / veterinary
            • Glucose Transport Proteins, Facilitative / metabolism
            • Glucose Transporter Type 4 / metabolism
            • Horses
            • Insulin Resistance / physiology
            • Intra-Abdominal Fat / metabolism
            • Intra-Abdominal Fat / pathology
            • Subcutaneous Fat / metabolism
            • Subcutaneous Fat / pathology

            Grant Funding

            • K01 RR023083 / NCRR NIH HHS
            • K01 RR023083-03 / NCRR NIH HHS
            • K01RR023083-01 / NCRR NIH HHS

            References

            This article includes 42 references
            1. American Diabetes Association: Prediabetes FAQS. [Accessed 1/8/11]. 2010. Available at http://www.diabetes.org/diabetes-basics/prevention/pre-diabetes/pre-diabetes-faqs.html.
            2. Ionut V, Liu H, Mooradian V, Castro AV, Kabir M, Stefanovski D, Zheng D, Kirkman EL, Bergman RN. Novel canine models of obese prediabetes and mild type 2 diabetes.. Am J Physiol Endocrinol Metab 2010 Jan;298(1):E38-48.
              pmc: PMC2806110pubmed: 19843874doi: 10.1152/ajpendo.00466.2009google scholar: lookup
            3. Shepherd PR, Kahn BB. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.. N Engl J Med 1999 Jul 22;341(4):248-57.
              pubmed: 10413738doi: 10.1056/nejm199907223410406google scholar: lookup
            4. Lee J, Xu Y, Lu L, Bergman B, Leitner JW, Greyson C, Draznin B, Schwartz GG. Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity.. Am J Physiol Heart Circ Physiol 2010 Feb;298(2):H310-9.
              pmc: PMC2822577pubmed: 19897715doi: 10.1152/ajpheart.00359.2009google scholar: lookup
            5. Frank N, Geor RJ, Bailey SR, Durham AE, Johnson PJ. Equine metabolic syndrome.. J Vet Intern Med 2010 May-Jun;24(3):467-75.
              pubmed: 20384947doi: 10.1111/j.1939-1676.2010.0503.xgoogle scholar: lookup
            6. Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review.. Nutr Metab (Lond) 2004 Nov 5;1(1):12.
              pmc: PMC535537pubmed: 15530168doi: 10.1186/1743-7075-1-12google scholar: lookup
            7. Cartwright MJ, Tchkonia T, Kirkland JL. Aging in adipocytes: potential impact of inherent, depot-specific mechanisms.. Exp Gerontol 2007 Jun;42(6):463-71.
              pmc: PMC1961638pubmed: 17507194doi: 10.1016/j.exger.2007.03.003google scholar: lookup
            8. MacLaren R, Cui W, Simard S, Cianflone K. Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue.. J Lipid Res 2008 Feb;49(2):308-23.
              pubmed: 17986714doi: 10.1194/jlr.m700199-jlr200google scholar: lookup
            9. Bajzová M, Kováčiková M, Vítková M, Klimčáková E, Polák J, Kováčová Z, Viguerie N, Vedral T, Mikulášek L, Šrámková P, Srp A, Hejnová J, Langin D, Stich V. Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity.. Physiol Res 2008;57(6):927-934.
              pubmed: 18052678doi: 10.33549/physiolres.931379google scholar: lookup
            10. Takahashi M, Eto M, Makino I. Peripheral insulin resistance precedes the onset of hyperglycemia in spontaneously diabetic Chinese hamsters of Asahikawa colony.. Diabetes Res Clin Pract 1993 May;20(2):101-9.
              pubmed: 8375262doi: 10.1016/0168-8227(93)90003-ngoogle scholar: lookup
            11. Carvalho E, Jansson PA, Axelsen M, Eriksson JW, Huang X, Groop L, Rondinone C, Sjöström L, Smith U. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM.. FASEB J 1999 Dec;13(15):2173-8.
              pubmed: 10593864doi: 10.1096/fasebj.13.15.2173google scholar: lookup
            12. Rogers S, Macheda ML, Docherty SE, Carty MD, Henderson MA, Soeller WC, Gibbs EM, James DE, Best JD. Identification of a novel glucose transporter-like protein-GLUT-12.. Am J Physiol Endocrinol Metab 2002 Mar;282(3):E733-8.
              pubmed: 11832379doi: 10.1152/ajpendo.2002.282.3.e733google scholar: lookup
            13. Stuart CA, Howell ME, Zhang Y, Yin D. Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle.. J Clin Endocrinol Metab 2009 Sep;94(9):3535-42.
              pmc: PMC2741719pubmed: 19549745doi: 10.1210/jc.2009-0162google scholar: lookup
            14. Sakamoto K, Holman GD. Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic.. Am J Physiol Endocrinol Metab 2008 Jul;295(1):E29-37.
              pmc: PMC2493596pubmed: 18477703doi: 10.1152/ajpendo.90331.2008google scholar: lookup
            15. Muno JD. Prevalence, risk factors and seasonality of plasma insulin concentrations in normal horses in central Ohio. MSc thesis. The Ohio State University; 2009.
            16. Burns TA, Geor RJ, Mudge MC, McCutcheon LJ, Hinchcliff KW, Belknap JK. Proinflammatory cytokine and chemokine gene expression profiles in subcutaneous and visceral adipose tissue depots of insulin-resistant and insulin-sensitive light breed horses.. J Vet Intern Med 2010 Jul-Aug;24(4):932-9.
              pubmed: 20649750doi: 10.1111/j.1939-1676.2010.0551.xgoogle scholar: lookup
            17. Waller AP, Burns TA, Mudge MC, Belknap JK, Lacombe VA. Insulin resistance selectively alters cell-surface glucose transporters but not their total protein expression in equine skeletal muscle.. J Vet Intern Med 2011 Mar-Apr;25(2):315-21.
              pubmed: 21314720doi: 10.1111/j.1939-1676.2010.0674.xgoogle scholar: lookup
            18. Hoffman RM, Boston RC, Stefanovski D, Kronfeld DS, Harris PA. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings.. J Anim Sci 2003 Sep;81(9):2333-42.
              pubmed: 12968709doi: 10.2527/2003.8192333xgoogle scholar: lookup
            19. Ryder JW, Yang J, Galuska D, Rincón J, Björnholm M, Krook A, Lund S, Pedersen O, Wallberg-Henriksson H, Zierath JR, Holman GD. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients.. Diabetes 2000 Apr;49(4):647-54.
              pubmed: 10871204doi: 10.2337/diabetes.49.4.647google scholar: lookup
            20. Koumanov F, Yang J, Jones AE, Hatanaka Y, Holman GD. Cell-surface biotinylation of GLUT4 using bis-mannose photolabels.. Biochem J 1998 Mar 15;330 ( Pt 3)(Pt 3):1209-15.
              pmc: PMC1219263pubmed: 9494087doi: 10.1042/bj3301209google scholar: lookup
            21. Lacombe VA, Hinchcliff KW, Devor ST. Effects of exercise and glucose administration on content of insulin-sensitive glucose transporter in equine skeletal muscle.. Am J Vet Res 2003 Dec;64(12):1500-6.
              pubmed: 14672428doi: 10.2460/ajvr.2003.64.1500google scholar: lookup
            22. BLAST BLAST protein sequence database. [Accessed 5/21/2010]. 2010. Available at: http://blast.ncbi.nlm.nih.gov/Blast.cgi.
            23. Lundgren M, Burén J, Ruge T, Myrnäs T, Eriksson JW. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes.. J Clin Endocrinol Metab 2004 Jun;89(6):2989-97.
              pubmed: 15181089doi: 10.1210/jc.2003-031157google scholar: lookup
            24. Laviola L, Perrini S, Cignarelli A, Natalicchio A, Leonardini A, De Stefano F, Cuscito M, De Fazio M, Memeo V, Neri V, Cignarelli M, Giorgino R, Giorgino F. Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.. Diabetes 2006 Apr;55(4):952-61.
              pubmed: 16567516doi: 10.2337/diabetes.55.04.06.db05-1414google scholar: lookup
            25. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance.. Physiol Rev 2004 Jan;84(1):277-359.
              pubmed: 14715917doi: 10.1152/physrev.00015.2003google scholar: lookup
            26. Ralston SL, Nockels CF, Squires EL. Differences in diagnostic test results and hematologic data between aged and young horses.. Am J Vet Res 1988 Aug;49(8):1387-92.
              pubmed: 3052193
            27. Geor RJ, Harris P. Dietary management of obesity and insulin resistance: countering risk for laminitis.. Vet Clin North Am Equine Pract 2009 Apr;25(1):51-65, vi.
              pubmed: 19303550doi: 10.1016/j.cveq.2009.02.001google scholar: lookup
            28. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction.. Diabetes 2002 Feb;51 Suppl 1:S212-20.
              pubmed: 11815482doi: 10.2337/diabetes.51.2007.s212google scholar: lookup
            29. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.. Nature 2001 Feb 8;409(6821):729-33.
              pubmed: 11217863doi: 10.1038/35055575google scholar: lookup
            30. Gómez-Ruiz A, Milagro FI, Campión J, Martínez JA, de Miguel C. Caveolin expression and activation in retroperitoneal and subcutaneous adipocytes: influence of a high-fat diet.. J Cell Physiol 2010 Oct;225(1):206-13.
              pubmed: 20506294doi: 10.1002/jcp.22241google scholar: lookup
            31. Kelly KR, Kashyap SR, O'Leary VB, Major J, Schauer PR, Kirwan JP. Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients.. Obesity (Silver Spring) 2010 Apr;18(4):663-6.
              pmc: PMC2919818pubmed: 19816414doi: 10.1038/oby.2009.328google scholar: lookup
            32. Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters.. Diabetes 1993 Dec;42(12):1773-85.
              pubmed: 8243823doi: 10.2337/diab.42.12.1773google scholar: lookup
            33. Gollisch KS, Brandauer J, Jessen N, Toyoda T, Nayer A, Hirshman MF, Goodyear LJ. Effects of exercise training on subcutaneous and visceral adipose tissue in normal- and high-fat diet-fed rats.. Am J Physiol Endocrinol Metab 2009 Aug;297(2):E495-504.
              pmc: PMC2724117pubmed: 19491293doi: 10.1152/ajpendo.90424.2008google scholar: lookup
            34. Carvalho E, Eliasson B, Wesslau C, Smith U. Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from Type II diabetic subjects.. Diabetologia 2000 Sep;43(9):1107-15.
              pubmed: 11043856doi: 10.1007/s001250051501google scholar: lookup
            35. Maianu L, Keller SR, Garvey WT. Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking.. J Clin Endocrinol Metab 2001 Nov;86(11):5450-6.
              pubmed: 11701721doi: 10.1210/jcem.86.11.8053google scholar: lookup
            36. Dreyer HC, Drummond MJ, Glynn EL, Fujita S, Chinkes DL, Volpi E, Rasmussen BB. Resistance exercise increases human skeletal muscle AS160/TBC1D4 phosphorylation in association with enhanced leg glucose uptake during postexercise recovery.. J Appl Physiol (1985) 2008 Dec;105(6):1967-74.
              pmc: PMC2612462pubmed: 18845784doi: 10.1152/japplphysiol.90562.2008google scholar: lookup
            37. Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, Wallberg-Henriksson H. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects.. Diabetes 2005 Jun;54(6):1692-7.
              pubmed: 15919790doi: 10.2337/diabetes.54.6.1692google scholar: lookup
            38. Lessard SJ, Rivas DA, Chen ZP, Bonen A, Febbraio MA, Reeder DW, Kemp BE, Yaspelkis BB 3rd, Hawley JA. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.. Diabetes 2007 Jul;56(7):1856-64.
              pubmed: 17440174doi: 10.2337/db06-1065google scholar: lookup
            39. Funai K, Cartee GD. Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle.. Diabetes 2009 May;58(5):1096-104.
              pmc: PMC2671042pubmed: 19208911doi: 10.2337/db08-1477google scholar: lookup
            40. Bai L, Wang Y, Fan J, Chen Y, Ji W, Qu A, Xu P, James DE, Xu T. Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action.. Cell Metab 2007 Jan;5(1):47-57.
              pubmed: 17189206doi: 10.1016/j.cmet.2006.11.013google scholar: lookup
            41. Huang S, Czech MP. The GLUT4 glucose transporter.. Cell Metab 2007 Apr;5(4):237-52.
              pubmed: 17403369doi: 10.1016/j.cmet.2007.03.006google scholar: lookup
            42. Watson RT, Pessin JE. GLUT4 translocation: the last 200 nanometers.. Cell Signal 2007 Nov;19(11):2209-17.
              pubmed: 17629673doi: 10.1016/j.cellsig.2007.06.003google scholar: lookup

            Citations

            This article has been cited 15 times.
            1. Stafeev I, Sklyanik I, Mamontova E, Michurina S, Shestakova E, Yah'yaev K, Yurasov A, Masnikov D, Sineokaya M, Ratner E, Vorotnikov A, Menshikov M, Parfyonova Y, Shestakova M. NDRG1 Activity in Fat Depots Is Associated With Type 2 Diabetes and Impaired Incretin Profile in Patients With Morbid Obesity. Front Endocrinol (Lausanne) 2021;12:777589.
              doi: 10.3389/fendo.2021.777589pubmed: 34956089google scholar: lookup
            2. Badoiu SC, Miricescu D, Stanescu-Spinu II, Ripszky Totan A, Badoiu SE, Costagliola M, Greabu M. Glucose Metabolism in Burns-What Happens?. Int J Mol Sci 2021 May 13;22(10).
              doi: 10.3390/ijms22105159pubmed: 34068151google scholar: lookup
            3. Campolo A, Frantz MW, de Laat MA, Hartson SD, Furr MO, Lacombe VA. Differential Proteomic Expression of Equine Cardiac and Lamellar Tissue During Insulin-Induced Laminitis. Front Vet Sci 2020;7:308.
              doi: 10.3389/fvets.2020.00308pubmed: 32596266google scholar: lookup
            4. Shoop S, Maria Z, Campolo A, Rashdan N, Martin D, Lovern P, Lacombe VA. Glial Growth Factor 2 Regulates Glucose Transport in Healthy Cardiac Myocytes and During Myocardial Infarction via an Akt-Dependent Pathway. Front Physiol 2019;10:189.
              doi: 10.3389/fphys.2019.00189pubmed: 30971932google scholar: lookup
            5. Durham AE, Frank N, McGowan CM, Menzies-Gow NJ, Roelfsema E, Vervuert I, Feige K, Fey K. ECEIM consensus statement on equine metabolic syndrome. J Vet Intern Med 2019 Mar;33(2):335-349.
              doi: 10.1111/jvim.15423pubmed: 30724412google scholar: lookup
            6. Jacob SI, Murray KJ, Rendahl AK, Geor RJ, Schultz NE, McCue ME. Metabolic perturbations in Welsh Ponies with insulin dysregulation, obesity, and laminitis. J Vet Intern Med 2018 May;32(3):1215-1233.
              doi: 10.1111/jvim.15095pubmed: 29572947google scholar: lookup
            7. Auger C, Samadi O, Jeschke MG. The biochemical alterations underlying post-burn hypermetabolism. Biochim Biophys Acta Mol Basis Dis 2017 Oct;1863(10 Pt B):2633-2644.
              doi: 10.1016/j.bbadis.2017.02.019pubmed: 28219767google scholar: lookup
            8. Maria Z, Campolo AR, Lacombe VA. Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria. PLoS One 2015;10(12):e0146033.
              doi: 10.1371/journal.pone.0146033pubmed: 26720696google scholar: lookup
            9. de Laat MA, Gruntmeir KJ, Pollitt CC, McGowan CM, Sillence MN, Lacombe VA. Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart. Front Endocrinol (Lausanne) 2014;5:120.
              doi: 10.3389/fendo.2014.00120pubmed: 25101057google scholar: lookup
            10. Lacombe VA. Expression and regulation of facilitative glucose transporters in equine insulin-sensitive tissue: from physiology to pathology. ISRN Vet Sci 2014;2014:409547.
              doi: 10.1155/2014/409547pubmed: 24977043google scholar: lookup
            11. Bruynsteen L, Erkens T, Peelman LJ, Ducatelle R, Janssens GP, Harris PA, Hesta M. Expression of inflammation-related genes is associated with adipose tissue location in horses. BMC Vet Res 2013 Dec 2;9:240.
              doi: 10.1186/1746-6148-9-240pubmed: 24295090google scholar: lookup
            12. Pujol-Giménez J, Barrenetxe J, González-Muniesa P, Lostao MP. The facilitative glucose transporter GLUT12: what do we know and what would we like to know?. J Physiol Biochem 2013 Jun;69(2):325-33.
              doi: 10.1007/s13105-012-0213-8pubmed: 23385668google scholar: lookup
            13. Ware B, Bevier M, Nishijima Y, Rogers S, Carnes CA, Lacombe VA. Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters. Am J Physiol Regul Integr Comp Physiol 2011 Nov;301(5):R1300-6.
              doi: 10.1152/ajpregu.00822.2010pubmed: 21849635google scholar: lookup
            14. Campolo A, Maria Z, Lacombe VA. Diabetes Causes Significant Alterations in Pulmonary Glucose Transporter Expression. Metabolites 2024 May 7;14(5).
              doi: 10.3390/metabo14050267pubmed: 38786744google scholar: lookup
            15. Burgos M, Gil-Iturbe E, Idoate-Bayón A, Castilla-Madrigal R, Moreno-Aliaga MJ, Lostao MP. The glucose transporter GLUT12, a new actor in obesity and cancer. J Physiol Biochem 2025 May;81(2):391-401.
              doi: 10.1007/s13105-024-01028-9pubmed: 38727993google scholar: lookup
            Subscribe to our newsletter
            Join 99,658 horse owners like you who receive our email updates on horse health and nutrition.